Last reviewed · How we verify
ASP8302
At a glance
| Generic name | ASP8302 |
|---|---|
| Sponsor | Astellas Pharma Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of ASP8302 in Participants With Underactive Bladder (PHASE2)
- ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ASP8302 CI brief — competitive landscape report
- ASP8302 updates RSS · CI watch RSS
- Astellas Pharma Inc portfolio CI